Craig Ostroff

Conference Coverage

Can Real-World Evidence Improve Clinical Pathways?

10/14/2022

At the 2022 Oncology Clinical Pathway Congress, Rebecca Miksad, MD, MPH, Flatiron Health; and Carole Tremonti, RN, MBA, Three Mountains LLC, presented how population-level data provides specificity and creates value in aiding decision-making.

At the 2022 Oncology Clinical...

10/14/2022

Journal of Clinical Pathways

Conference Coverage

Comparing BTKis Acalabrutinib and Ibrutinib in Real-World Analysis of Patients With CLL

12/12/2022

Craig Ostroff ;

At the 64th ASH Annual Meeting and Exposition, Lindsey E Roeker, MD, and colleagues present a real-world analysis comparing CV and bleeding AEs as well as PFS in patients with CLL treated with acalabrutinib vs those treated with ibrutinib.

At the 64th ASH Annual Meeting...

12/12/2022

Journal of Clinical Pathways

Conference Coverage

Value-Based Oncology Care Solutions for Self-Insured Employers

10/15/2022

Craig Ostroff ;

At the 2022 Oncology Clinical Pathways Congress, Margaret Rehayem, Vice President of the National Alliance of Healthcare Purchaser Coalitions, spoke on the dramatic effect that developments in cancer care have had on employers and employees.

At the 2022 Oncology Clinical...

10/15/2022

Journal of Clinical Pathways